Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin <sup>177</sup>Lu-PP-F11N.

Grob, Nathalie M; Schibli, Roger; Béhé, Martin; Mindt, Thomas L

Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin ¹⁷⁷Lu-PP-F11N.

Grob, Nathalie M; Schibli, Roger; Béhé, Martin; Mindt, Thomas L.

Afiliação

Grob NM; Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, 8093 Zurich, Switzerland.
Schibli R; Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, 8093 Zurich, Switzerland.
Béhé M; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen, Switzerland.
Mindt TL; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen, Switzerland.

Cancers (Basel) ; 13(11)2021 May 27.

Article em En | MEDLINE | ID: mdl-34071914

Palavras-chave

cholecystokinin-2 receptor; minigastrin; molecular imaging; peptide receptor radionuclide therapy; peptidomimetics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google